| Financial Year |
March 31 2023 |
| Monetary Funds |
109,788,690,280.68 |
| Held-for-trading Financial Assets |
268,415,428.68 |
| Notes Receivable |
2,348,930,598.62 |
| Accounts Receivable |
110,972,937,538.38 |
| Advances to Suppliers |
34,692,641,680.06 |
| Other Receivables |
30,681,748,054.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
725,835,008.57 |
| Inventories |
18,746,197,672.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
6,825,613,277.74 |
| Other Current Assets |
15,054,768,365.96 |
| Total Current Assets |
464,355,325,398.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
57,505,832,129.54 |
| Long-term Equity Investment |
30,212,049,442.18 |
| Investment Properties |
2,136,449,741.85 |
| Fixed Assetes |
124,843,063,074.86 |
| Under-construction Projects |
28,325,161,127.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
6,106,408.21 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,497,392,824.46 |
| R&D expenses |
6,802,375.23 |
| Goodwill |
375,696,031.99 |
| Long-Term Deferred and Prepaid Expenses |
1,495,190,824.64 |
| Deferred Income Tax Assets |
5,357,087,973.80 |
| Other Non-Current Assets |
88,807,388,988.70 |
| Sub-Total of Non-Current Assets |
642,269,859,635.22 |
| Total Assets |
1,106,625,185,033.97 |
| Short-Term Loans |
58,475,126,361.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,142,092,914.42 |
| Accounts Payable |
192,246,584,902.91 |
| Accounts Received In Advance |
397,122,177.28 |
| Employee Compensation Payable |
2,564,061,324.78 |
| Taxes Payable |
2,612,500,856.29 |
| Interest Payable |
-- |
| Dividend Payable |
1,112,866,092.15 |
| Other payables |
66,057,284,820.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,986,246,142.20 |
| Other Current Liabilities |
23,409,685,651.14 |
| Sub-Total of Current Liabilities |
506,910,304,963.42 |
| Long-term Loans |
310,771,103,754.93 |
| Bonds Payable |
13,899,386,792.53 |
| Long-Term Accounts Payable |
9,264,902,165.99 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,715,422,107.10 |
| Deferred Income Tax Liabilities |
3,159,712,183.77 |
| Other Non-Current Liabilities |
2,951,103,072.84 |
| Sub-Total of Non-Current Liabilities |
353,723,266,085.63 |
| Total Liabilities |
860,633,571,049.05 |
| Paid-In Capital(Or Share Stock) |
17,226,159,334.00 |
| Capital Surplus |
35,791,496,370.85 |
| Surplus Reserve |
2,811,152,171.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
63,125,346,813.44 |
| Minority Stockholder's Interest |
89,335,762,401.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
156,655,851,582.99 |
| Owner's Equity（Stockholder's Equity） |
245,991,613,984.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,106,625,185,033.97 |
